| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jerry R Mendell, Navid Khan, Nanshi Sha, Helen Eliopoulos, Craig M McDonald, Nathalie Goemans, Eugenio Mercuri, Linda P Lowes, Lindsay N Alfan. Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls. Journal of neuromuscular diseases. vol 8. issue 4. 2021-09-10. PMID:33523015. |
duchenne muscular dystrophy (dmd) is a rare, x-linked, fatal, degenerative neuromuscular disease caused by dmd gene mutations. |
2021-09-10 |
2023-08-13 |
Not clear |
| Yu Zhang, Takahiko Nishiyama, Hui Li, Jian Huang, Ayhan Atmanli, Efrain Sanchez-Ortiz, Zhaoning Wang, Alex A Mireault, Pradeep P A Mammen, Rhonda Bassel-Duby, Eric N Olso. A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation. Molecular therapy. Methods & clinical development. vol 22. 2021-09-07. PMID:34485599. |
duchenne muscular dystrophy (dmd), caused by mutations in the x-linked dystrophin gene, is a lethal neuromuscular disease. |
2021-09-07 |
2023-08-13 |
Not clear |
| Mohsan Iftikhar, Justin Frey, Md Jasimuddin Shohan, Sohail Malek, Shaker A Mous. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy. Pharmacology & therapeutics. vol 220. 2021-08-16. PMID:33130193. |
two of the most prevalent neuromuscular diseases are duchenne muscular dystrophy (dmd) and spinal muscular atrophy (sma), which are often diagnosed during the early years of life, contributing to life-long debilitation and shorter longevity. |
2021-08-16 |
2023-08-13 |
Not clear |
| Andrea L Reid, Matthew S Alexande. The Interplay of Mitophagy and Inflammation in Duchenne Muscular Dystrophy. Life (Basel, Switzerland). vol 11. issue 7. 2021-08-09. PMID:34357020. |
duchenne muscular dystrophy (dmd) is an x-linked neuromuscular disease caused by a pathogenic disruption of the |
2021-08-09 |
2023-08-13 |
Not clear |
| Douglas W Van Pelt, Yalda A Kharaz, Dylan C Sarver, Logan R Eckhardt, Justin T Dzierzawski, Nathaniel P Disser, Alex N Piacentini, Eithne Comerford, Brian McDonagh, Christopher L Mendia. Multiomics analysis of the mdx/mTR mouse model of Duchenne muscular dystrophy. Connective tissue research. vol 62. issue 1. 2021-07-08. PMID:32664808. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease characterized by extensive muscle weakness. |
2021-07-08 |
2023-08-13 |
mouse |
| Tatyana A Meyers, Jackie A Heitzman, DeWayne Townsen. DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury. Human molecular genetics. vol 29. issue 6. 2021-07-05. PMID:31976522. |
duchenne muscular dystrophy (dmd) is a devastating neuromuscular disease that causes progressive muscle wasting and cardiomyopathy. |
2021-07-05 |
2023-08-13 |
mouse |
| Stephanie Kourakis, Cara A Timpani, Judy B de Haan, Nuri Gueven, Dirk Fischer, Emma Rybalk. Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy. Redox biology. vol 38. 2021-06-18. PMID:33246292. |
imbalances in redox homeostasis can result in oxidative stress, which is implicated in various pathological conditions including the fatal neuromuscular disease duchenne muscular dystrophy (dmd). |
2021-06-18 |
2023-08-13 |
Not clear |
| Arun Sadasivan, Manjusha G Warrier, Kiran Polavarapu, Veeramani Preethish-Kumar, Meera G Nair, M S Keerthipriya, Seena Vengalil, John Vijay Sagar, Thomas Kishore, Atchayaram Nalini, Priya Treesa Thoma. Palliative Care in Duchenne Muscular Dystrophy: A Study on Parents' Understanding. Indian journal of palliative care. vol 27. issue 1. 2021-05-28. PMID:34035633. |
duchene muscular dystrophy (dmd) is a neuromuscular disease of childhood, which has clear progression. |
2021-05-28 |
2023-08-13 |
Not clear |
| Xia Dong, Tiankun Hui, Jie Chen, Zheng Yu, Dongyan Ren, Suqi Zou, Shunqi Wang, Erkang Fei, Huifeng Jiao, Xinsheng La. Metformin Frontiers in physiology. vol 12. 2021-05-22. PMID:34012406. |
metformin duchenne muscular dystrophy (dmd) is a genetic neuromuscular disease characterized by progressive muscle weakness and wasting. |
2021-05-22 |
2023-08-13 |
mouse |
| P Lamendola, G A Lanza, V Melita, A Villano, C Palermo, D Leone, A Lombardo, F Pennestrì, F Crea, E M Mercuri, M Pan. Duchenne muscular dystrophy: preliminary experience with sacubitril-valsartan in patients with asymptomatic left ventricular dysfunction. European review for medical and pharmacological sciences. vol 24. issue 17. 2021-05-17. PMID:32965001. |
duchenne muscular dystrophy (dmd) is an inherited x-linked recessive neuromuscular disease caused by mutations of the dystrophin gene, leading to early and progressive muscle deterioration and dilated cardiomyopathy. |
2021-05-17 |
2023-08-13 |
Not clear |
| Richard M Lovering, Shama R Iyer, Benjamin Edwards, Kay E Davie. Alterations of neuromuscular junctions in Duchenne muscular dystrophy. Neuroscience letters. vol 737. 2021-04-30. PMID:32818587. |
the focus of this review is on duchenne muscular dystrophy (dmd), which is caused by the absence of the protein dystrophin and is characterized as a neuromuscular disease in which muscle weakness, increased susceptibility to muscle injury, and inadequate repair appear to underlie the pathology. |
2021-04-30 |
2023-08-13 |
human |
| Rachael A Potter, Danielle A Griffin, Kristin N Heller, Ellyn L Peterson, Emma K Clark, Jerry R Mendell, Louise R Rodino-Klapa. Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the Human gene therapy. vol 32. issue 7-8. 2021-04-26. PMID:33397205. |
dose-escalation study of systemically delivered raavrh74.mhck7.micro-dystrophin in the duchenne muscular dystrophy (dmd) is a rare, x-linked, fatal, degenerative neuromuscular disease caused by mutations in the |
2021-04-26 |
2023-08-13 |
Not clear |
| Guenther Bernert, Andreas Hahn, Cornelia Köhler, Sascha Meyer, Ulrike Schara, Kurt Schlachter, Regina Trollmann, Maggie C Walte. [Expert recommendation: treatment of nonambulatory patients with Duchenne muscular dystrophy]. Der Nervenarzt. vol 92. issue 4. 2021-04-09. PMID:33215271. |
duchenne muscular dystrophy (dmd) is the most frequent genetic neuromuscular disease in childhood with loss of ambulation usually occurring around the age of 9-11 years. |
2021-04-09 |
2023-08-13 |
Not clear |
| Tianyuan Zhang, Xiangdong Kon. Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review). Experimental and therapeutic medicine. vol 21. issue 5. 2021-03-30. PMID:33777191. |
duchenne muscular dystrophy (dmd) is the most common degenerative neuromuscular disease. |
2021-03-30 |
2023-08-13 |
Not clear |
| Wen-Bin Zheng, Yi Dai, Jing Hu, Di-Chen Zhao, Ou Wang, Yan Jiang, Wei-Bo Xia, Xiao-Ping Xing, Mei L. Effects of Bisphosphonates on Osteoporosis Induced by Duchenne Muscular Dystrophy: A Prospective Study. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. vol 26. issue 12. 2021-01-22. PMID:33471740. |
duchenne muscular dystrophy (dmd) is a severe x-linked progressive neuromuscular disease that brings a significantly increased risk of osteoporosis and bone fractures. |
2021-01-22 |
2023-08-13 |
Not clear |
| Justin S Dhindsa, Angela L McCall, Laura M Strickland, Anna F Fusco, Amanda F Kahn, Mai K ElMalla. Motor axonopathies in a mouse model of Duchenne muscular dystrophy. Scientific reports. vol 10. issue 1. 2021-01-21. PMID:32488044. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease caused by deleterious mutations in the dmd gene which encodes the dystrophin protein. |
2021-01-21 |
2023-08-13 |
mouse |
| Karima Relizani, Graziella Griffith, Lucía Echevarría, Faouzi Zarrouki, Patricia Facchinetti, Cyrille Vaillend, Christian Leumann, Luis Garcia, Aurélie Goyenvall. Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model. Molecular therapy. Nucleic acids. vol 8. 2021-01-09. PMID:28918017. |
a novel class of aons made of tricyclo-dna (tcdna) is considered very promising for the treatment of duchenne muscular dystrophy (dmd), a neuromuscular disease typically caused by frameshifting deletions or nonsense mutations in the gene-encoding dystrophin and characterized by progressive muscle weakness, cardiomyopathy, and respiratory failure in addition to cognitive impairment. |
2021-01-09 |
2023-08-13 |
mouse |
| Zubiao Song, Yanmei Liu, Xiaobo Fang, Mengshu Xie, Zhenyu Ma, Zhigang Zhong, Xuelin Feng, Weixi Zhan. Comprehensive analysis of the expression profile of circRNAs and their predicted protein-coding ability in the muscle of mdx mice. Functional & integrative genomics. vol 20. issue 3. 2021-01-04. PMID:31736012. |
duchenne muscular dystrophy (dmd) is an x-linked genetic neuromuscular disease that is characterized by progressive muscle wasting and by defects in the regenerative capacity and inflammatory infiltration of muscle. |
2021-01-04 |
2023-08-13 |
mouse |
| Anne Troike Stratton, Richard Ogden Roberts Iii, Oren Kupfer, Terri Carry, Julie Parsons, Susan Apko. Pediatric neuromuscular disorders: Care considerations during the COVID-19 pandemic. Journal of pediatric rehabilitation medicine. vol 13. issue 3. 2020-12-23. PMID:33185615. |
patients with neuromuscular diseases such as those with duchenne muscular dystrophy (dmd) and spinal muscular atrophy (sma), tend to be more medically fragile and have higher health care needs than the general population. |
2020-12-23 |
2023-08-13 |
Not clear |
| Fumi Takeuchi, Harumasa Nakamura, Naohiro Yonemoto, Hirofumi Komaki, Raymond L Rosales, Andrew J Kornberg, Allan H Bretag, Charungthai Dejthevaporn, Khean Jin Goh, Yuh-Jyh Jong, Dae-Seong Kim, Satish V Khadilkar, Dingguo Shen, Kum Thong Wong, Josiah Chai, Sophelia Hoi-Shan Chan, Sara Khan, Ohnmar Ohnmar, Ichizo Nishino, Shin'ichi Takeda, Ikuya Nonak. Clinical practice with steroid therapy for Duchenne muscular dystrophy: An expert survey in Asia and Oceania. Brain & development. vol 42. issue 3. 2020-10-23. PMID:31980267. |
in 2015, we conducted a dmd expert survey in asia and oceania to acquire information regarding patients with dmd and to assess current clinical practice with the cooperation of asian and oceanian myology centre, a neuromuscular disease research network. |
2020-10-23 |
2023-08-13 |
Not clear |